Clinical evaluation of floctafenine (Idalon) for postexodontic pain compared with mefenamic acid (Pontal).
スポンサーリンク
概要
- 論文の詳細を見る
A single blind study was conducted to evaluate the analgesic efficacy of floctafenine (400 mg), in comparison with mefenamic acid (500 mg) on postexodontic pain. The results obtained were as follows:<BR>1) Of the total of 41 cases analyzed, 22 cases were treated with floctafenine (I group) and 19 cases were treated with mefenamic acid (P group) .<BR>2) There was no statistically significant difference between the two groups for the background parameters considered.<BR>3) According to both the doctor's and the patient's judgement of the pain improvement rating, there was no significant difference between the two groups.<BR>4) According to a numerical judgement of the pain improvement rating, the I group was significantly superior to the P group (<I>p</I><0.05) . However, according to this judgement, there was no significant difference between the two groups in time until the appearance of effect and duration of successive effect after administration.<BR>5) One case of side effects was reported in each of the I and P groups.<BR>6) In the overall clinical evaluation rating, the I group was superior to the P group on the ratio rated"markedly useful" (<I>p</I><0.05) .<BR>These results indicate that the administration of 400 mg floctafenine is useful for post-exodontic pain.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果